How Cardiologists’ High Hopes for Two Drugs Were Dashed
Why This Matters
Key context: By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease? This development from The New York Times highlights ongoing changes in the sector.
By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?
Curation & Context
This page summarizes a public news report from The New York Times. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.